We help to Achieve Your Goal at all Drug Development Phases
Uncover insights with AI-driven analytics on mechanism of action, predictive and prognostic biomarkers, pharmacodynamics, disease mechanisms and target identification.
Provide pathology review and biomarker analysis services for toxicology histopathology, dose selection, mechanism of action and biomarker validation, in non-GLP and GLP settings.
Generate biomarker reports with AI-driven analytics to support patient enrichment, patient stratification, endpoint and surrogate analysis and covariate adjustments.
Pathology Review and Report
Quantitative Image Analysis
Multimodal Data Analytics
Integrate pathology image with multiple data modalities, including multi-omics and EMR data, to gain a holistic view of disease progression and treatment response.
Prognostic and Predictive Biomarker Modeling
Develop innovative predictive and prognostic biomarkers with by training and validating multimodal deep learning models to support clinical development.